RST-001 for Retinitis Pigmentosa
This trial is testing an experimental treatment for macular degeneration. It is enrolling 12 patients total, 6 of which must have very poor vision in the study eye, and 6 of which must have vision ranging from poor to 20/200.
- Retinitis Pigmentosa
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there numerous facilities administering the experiment within this state?
"At present, 4 medical centres are recruiting for this trial. Dallas, San Francisco and Cincinnati have established locations where patients can participate in the study while other cities house additional potential sites of enrolment. To reduce travelling burdens it is recommended to choose the closest location available when enrolling."
Is the recruitment process for this clinical trial currently underway?
"Clinicaltrials.gov shows that this research project is no longer accepting participants, as the last update to its posting was made on September 9th 2022. Despite this trial being inactive, there are 51 other trials actively recruiting patients at present time."